LU92176I2 - Glycopyrronium ou un de ses sels - Google Patents
Glycopyrronium ou un de ses selsInfo
- Publication number
- LU92176I2 LU92176I2 LU92176C LU92176C LU92176I2 LU 92176 I2 LU92176 I2 LU 92176I2 LU 92176 C LU92176 C LU 92176C LU 92176 C LU92176 C LU 92176C LU 92176 I2 LU92176 I2 LU 92176I2
- Authority
- LU
- Luxembourg
- Prior art keywords
- glycopyrronium
- salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0409703.6A GB0409703D0 (en) | 2004-04-30 | 2004-04-30 | Pharmaceutical compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
LU92176I2 true LU92176I2 (fr) | 2013-05-27 |
LU92176I9 LU92176I9 (fr) | 2019-01-04 |
Family
ID=32408337
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU92176C LU92176I2 (fr) | 2004-04-30 | 2013-03-27 | Glycopyrronium ou un de ses sels |
LU92392C LU92392I2 (fr) | 2004-04-30 | 2014-03-07 | Glycopyrronium ou un sel de celui-ci, plus particulèrement le sel bromure, combiné à indacatérol ou un sel de celui-ci, plus particlièrement le sel maléate |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU92392C LU92392I2 (fr) | 2004-04-30 | 2014-03-07 | Glycopyrronium ou un sel de celui-ci, plus particulèrement le sel bromure, combiné à indacatérol ou un sel de celui-ci, plus particlièrement le sel maléate |
Country Status (27)
Country | Link |
---|---|
US (1) | US20080063719A1 (fr) |
EP (3) | EP2422767A3 (fr) |
JP (2) | JP5000483B2 (fr) |
KR (1) | KR101287919B1 (fr) |
CN (3) | CN102008453A (fr) |
AU (2) | AU2005237266B2 (fr) |
BR (1) | BRPI0510500B8 (fr) |
CA (1) | CA2563760C (fr) |
CY (6) | CY1113069T1 (fr) |
DK (2) | DK2422766T3 (fr) |
ES (2) | ES2546982T3 (fr) |
GB (1) | GB0409703D0 (fr) |
HK (2) | HK1095282A1 (fr) |
HU (4) | HUE025463T2 (fr) |
IL (2) | IL178651A (fr) |
LT (1) | LTC2422766I2 (fr) |
LU (2) | LU92176I2 (fr) |
MX (2) | MXPA06012493A (fr) |
NO (1) | NO20065502L (fr) |
NZ (1) | NZ550479A (fr) |
PL (2) | PL2422766T3 (fr) |
PT (2) | PT1755555E (fr) |
RU (1) | RU2396943C2 (fr) |
SG (3) | SG186673A1 (fr) |
SI (2) | SI2422766T1 (fr) |
WO (1) | WO2005105043A2 (fr) |
ZA (1) | ZA200609350B (fr) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0409703D0 (en) * | 2004-04-30 | 2004-06-02 | Vectura Ltd | Pharmaceutical compositions |
GB0425758D0 (en) | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
GB0525254D0 (en) * | 2005-12-12 | 2006-01-18 | Jagotec Ag | Powder compositions for inhalation |
GB0613161D0 (en) | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
GB0622818D0 (en) * | 2006-11-15 | 2006-12-27 | Jagotec Ag | Improvements in or relating to organic compounds |
PT2229148E (pt) * | 2007-12-13 | 2014-05-26 | Novartis Ag | Processo para preparação de uma substância farmacológica particulada e substancialmente cristalina |
US20100247658A1 (en) * | 2007-12-13 | 2010-09-30 | Gerhard Muhrer | Organic compounds |
US20100055045A1 (en) | 2008-02-26 | 2010-03-04 | William Gerhart | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
AU2009241628A1 (en) * | 2008-02-26 | 2009-11-05 | Elevation Pharmaceuticals, Inc. | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
JP5809985B2 (ja) | 2009-02-26 | 2015-11-11 | グラクソ グループ リミテッドGlaxo Group Limited | 4−{(1r)−2−[(6−{2−[(2,6−ジクロロベンジル)オキシ]エトキシ}ヘキシル)アミノ]−1−ヒドロキシエチル}−2−(ヒドロキシメチル)フェノールを含む医薬製剤 |
CA2759041A1 (fr) * | 2009-04-24 | 2010-10-28 | Schering Corporation | Preparations d'agglomerat utiles dans des inhalateurs a poudre seche |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
GB0921481D0 (en) * | 2009-12-08 | 2010-01-20 | Vectura Ltd | Process and product |
US20130028977A1 (en) * | 2010-03-31 | 2013-01-31 | Glenmark Pharmaceuticals Limited | Pharmaceutical powder composition for inhalation |
RU2585101C2 (ru) | 2010-04-01 | 2016-05-27 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Способ приготовления частиц носителя для сухих порошков для ингаляции |
KR20130062268A (ko) * | 2010-04-21 | 2013-06-12 | 키에시 파르마슈티시 엣스. 피. 에이. | 정전하가 감소된 입자를 제공하는 방법 |
ES2705494T3 (es) | 2010-08-31 | 2019-03-25 | Glaxosmithkline Ip Dev Ltd | Productos farmacológicos para la inhalación de polvo seco que presentan propiedades de control de la humedad y procedimientos de administración de los mismos |
EP2611423B2 (fr) | 2010-08-31 | 2022-09-21 | GlaxoSmithKline Intellectual Property Development Limited | Produits médicamenteux pour inhalation sous forme de poudre sèche présentant propriétés de régulation d'humidité et leurs procédés d'administration |
JO3510B1 (ar) | 2011-03-04 | 2020-07-05 | Heptares Therapeutics Ltd | استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب |
JP6267685B2 (ja) | 2012-04-13 | 2018-01-24 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | 集合粒子 |
AU2013100007B4 (en) * | 2013-01-04 | 2013-05-23 | Novartis Ag | System for treating chronic obstructive pulmonary disease |
US9006462B2 (en) | 2013-02-28 | 2015-04-14 | Dermira, Inc. | Glycopyrrolate salts |
US8558008B2 (en) | 2013-02-28 | 2013-10-15 | Dermira, Inc. | Crystalline glycopyrrolate tosylate |
SG11201506789PA (en) | 2013-02-28 | 2015-09-29 | Dermira Inc | Glycopyrrolate salts |
MX361286B (es) * | 2013-03-15 | 2018-12-03 | Pearl Therapeutics Inc | Métodos y sistemas para el acondicionamiento de materiales cristalinos de partículas. |
GB201305825D0 (en) | 2013-03-28 | 2013-05-15 | Vectura Ltd | New use |
US9393202B2 (en) * | 2013-04-26 | 2016-07-19 | Chiesi Farmaceutici S.P.A | Particle size reduction of an antimuscarinic compound |
GB201402556D0 (en) | 2014-02-13 | 2014-04-02 | Crystec Ltd | Improvements relating to inhalable particles |
MA40617B1 (fr) * | 2014-09-09 | 2020-05-29 | Vectura Ltd | Formulation comprenant glycopyrrolate, procédé et appareil |
BR112017007587A2 (pt) * | 2014-10-16 | 2018-01-30 | Teva Branded Pharmaceutical Products R&D Inc | processo para preparar uma formulação farmacêutica em pó seca e inalável |
US9925168B2 (en) * | 2016-01-22 | 2018-03-27 | Chiesi Farmaceutici S.P.A. | Preparation of micronized particles of an antimuscarinic compound by hydrodynamic cavitation |
AU2016397046B2 (en) | 2016-03-08 | 2022-05-12 | Mereo Biopharma 1 Limited | Dosage regimen for the treatment of acute exacerbations of inflammatory conditions |
AU2016397047B2 (en) | 2016-03-08 | 2022-04-07 | Mereo Biopharma 1 Limited | Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease |
PT3490533T (pt) | 2016-07-29 | 2020-07-21 | Inke Sa | Processo de estabilização do tamanho de partícula |
BR112019005133A2 (pt) | 2016-09-19 | 2019-06-04 | Mexichem Fluor Sa De Cv | composição farmacêutica, recipiente vedado, inalador de dose medida, e, métodos para tratar um paciente sofrendo ou susceptível de sofrer de um distúrbio respiratório, para melhorar a estabilidade de uma composição farmacêutica, para melhoria do desempenho de dispersão em aerossol de uma composição farmacêutica e para reduzir o potencial de aquecimento global de uma composição farmacêutica. |
WO2018167180A1 (fr) * | 2017-03-15 | 2018-09-20 | Vectura Limited | Procédé et formulation |
WO2019060604A1 (fr) * | 2017-09-20 | 2019-03-28 | Teva Branded Pharmaceutical Products R&D, Inc. | Médicament inhalable |
WO2019060595A1 (fr) | 2017-09-20 | 2019-03-28 | Teva Branded Pharmaceutical Products R&D, Inc. | Médicament inhalable en poudre sèche comprenant du glycopyrronium |
WO2019116022A1 (fr) | 2017-12-11 | 2019-06-20 | Mereo Biopharma 1 Limited | Utilisation de 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-méthylbenzamide dans la prévention ou la réduction d'exacerbations aiguës de la bronchopneumopathie chronique obstructive |
US11701341B2 (en) | 2017-12-11 | 2023-07-18 | Mereo Biopharma 1 Limited | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease |
KR20200078162A (ko) | 2018-12-21 | 2020-07-01 | 한미약품 주식회사 | 흡입 제형용 건조 분말 및 이의 제조방법 |
WO2023117985A1 (fr) | 2021-12-21 | 2023-06-29 | Chiesi Farmaceutici S.P.A. | Formulations de poudre sèche remplies dans un inhalateur présentant une résistance à l'humidité améliorée |
WO2023117967A1 (fr) | 2021-12-21 | 2023-06-29 | Chiesi Farmaceutici S.P.A. | Formulations en poudre sèche remplies dans un inhalateur présentant une résistance à l'humidité améliorée |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2956062A (en) * | 1959-02-26 | 1960-10-11 | Robins Co Inc A H | Esters of amino alcohols |
US3709039A (en) * | 1970-08-31 | 1973-01-09 | Gen Time Corp | Comfort humidity indicator |
SE9302777D0 (sv) | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
US5612053A (en) * | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
GB9808470D0 (en) | 1998-04-22 | 1998-06-17 | Smithkline Beecham Plc | Novel process and apparatus |
RU2221552C2 (ru) * | 1998-11-13 | 2004-01-20 | Джаго Рисерч Аг | Сухой порошок для ингаляции |
GB9826286D0 (en) | 1998-12-01 | 1999-01-20 | Rhone Poulence Rorer Limited | Process |
GB9826284D0 (en) * | 1998-12-01 | 1999-01-20 | Rhone Poulence Rorer Limited | Process |
GB0008660D0 (en) * | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
PE20011227A1 (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
ATE378039T1 (de) | 2000-06-27 | 2007-11-15 | Vectura Ltd | Herstellungsverfahren für partikel zur verwendung in einer arzneizusammensetzung |
ES2296831T3 (es) * | 2000-11-30 | 2008-05-01 | Vectura Limited | Metodo para preparar microparticulas para usar en composiciones farmaceuticas para inhalacion. |
EP2283818B1 (fr) * | 2000-11-30 | 2017-08-02 | Vectura Limited | Procede de preparation de particules destinees a etre utilisees dans une composition pharmaceutique |
RU2294737C2 (ru) * | 2001-03-30 | 2007-03-10 | Яготек Аг | Медицинские аэрозольные составы |
CA2483914A1 (fr) * | 2002-05-07 | 2003-11-20 | Nektar Therapeutics | Capsules pour inhalateurs a poudre seche et procedes de fabrication et d'utilisation correspondants |
GB2405798A (en) * | 2003-09-15 | 2005-03-16 | Vectura Ltd | Dry powder inhaler with primary and secondary piercing elements and a medicament pack for use with an inhalation device. |
GB0409703D0 (en) * | 2004-04-30 | 2004-06-02 | Vectura Ltd | Pharmaceutical compositions |
WO2006100453A1 (fr) * | 2005-03-24 | 2006-09-28 | Sosei R & D Ltd. | Sels de glycopyrronium et leur application thérapeutique |
-
2004
- 2004-04-30 GB GBGB0409703.6A patent/GB0409703D0/en not_active Ceased
-
2005
- 2005-04-29 SG SG2012093886A patent/SG186673A1/en unknown
- 2005-04-29 PL PL11190637T patent/PL2422766T3/pl unknown
- 2005-04-29 ES ES11190637.6T patent/ES2546982T3/es active Active
- 2005-04-29 DK DK11190637.6T patent/DK2422766T3/da active
- 2005-04-29 SI SI200531999T patent/SI2422766T1/sl unknown
- 2005-04-29 PL PL05738040T patent/PL1755555T3/pl unknown
- 2005-04-29 CA CA2563760A patent/CA2563760C/fr active Active
- 2005-04-29 SG SG10201605001SA patent/SG10201605001SA/en unknown
- 2005-04-29 MX MXPA06012493A patent/MXPA06012493A/es active IP Right Grant
- 2005-04-29 HU HUE11190637A patent/HUE025463T2/en unknown
- 2005-04-29 BR BRPI0510500A patent/BRPI0510500B8/pt active IP Right Grant
- 2005-04-29 CN CN2010105642463A patent/CN102008453A/zh active Pending
- 2005-04-29 EP EP11190638A patent/EP2422767A3/fr not_active Withdrawn
- 2005-04-29 KR KR1020067024763A patent/KR101287919B1/ko active IP Right Grant
- 2005-04-29 SI SI200531570T patent/SI1755555T1/sl unknown
- 2005-04-29 JP JP2007510045A patent/JP5000483B2/ja active Active
- 2005-04-29 SG SG200903001-6A patent/SG152292A1/en unknown
- 2005-04-29 NZ NZ550479A patent/NZ550479A/en unknown
- 2005-04-29 CN CN201710357916.6A patent/CN107252423A/zh active Pending
- 2005-04-29 CN CNA200580013592XA patent/CN1964700A/zh active Pending
- 2005-04-29 PT PT05738040T patent/PT1755555E/pt unknown
- 2005-04-29 DK DK05738040.4T patent/DK1755555T3/da active
- 2005-04-29 ES ES05738040T patent/ES2388289T3/es active Active
- 2005-04-29 EP EP05738040A patent/EP1755555B1/fr not_active Revoked
- 2005-04-29 WO PCT/EP2005/051980 patent/WO2005105043A2/fr active Application Filing
- 2005-04-29 RU RU2006142322/15A patent/RU2396943C2/ru active Protection Beyond IP Right Term
- 2005-04-29 EP EP11190637.6A patent/EP2422766B1/fr not_active Revoked
- 2005-04-29 US US11/587,725 patent/US20080063719A1/en not_active Abandoned
- 2005-04-29 PT PT111906376T patent/PT2422766E/pt unknown
- 2005-04-29 AU AU2005237266A patent/AU2005237266B2/en active Active
-
2006
- 2006-10-16 IL IL178651A patent/IL178651A/en active IP Right Review Request
- 2006-10-27 MX MX2012008068A patent/MX341426B/es unknown
- 2006-11-10 ZA ZA2006/09350A patent/ZA200609350B/en unknown
- 2006-11-29 NO NO20065502A patent/NO20065502L/no not_active Application Discontinuation
-
2007
- 2007-02-23 HK HK07102081.9A patent/HK1095282A1/xx not_active IP Right Cessation
-
2011
- 2011-02-09 AU AU2011200543A patent/AU2011200543B2/en active Active
- 2011-11-08 JP JP2011244443A patent/JP5124718B2/ja active Active
-
2012
- 2012-08-13 CY CY20121100722T patent/CY1113069T1/el unknown
- 2012-08-16 HK HK12108085.5A patent/HK1167334A1/xx not_active IP Right Cessation
- 2012-12-10 IL IL223545A patent/IL223545A/en active IP Right Grant
-
2013
- 2013-03-13 HU HUS1300006C patent/HUS1300006I1/hu unknown
- 2013-03-27 LU LU92176C patent/LU92176I2/fr unknown
- 2013-03-29 CY CY2013012C patent/CY2013012I1/el unknown
-
2014
- 2014-03-07 LU LU92392C patent/LU92392I2/fr unknown
- 2014-03-19 CY CY2014015C patent/CY2014015I2/el unknown
-
2015
- 2015-08-27 CY CY20151100754T patent/CY1116655T1/el unknown
- 2015-12-18 LT LTPA2015053C patent/LTC2422766I2/lt unknown
- 2015-12-21 HU HUS1500073C patent/HUS1500073I1/hu unknown
- 2015-12-21 HU HUS1500072C patent/HUS1500072I1/hu unknown
- 2015-12-23 CY CY2015059C patent/CY2015059I1/el unknown
- 2015-12-23 CY CY2015060C patent/CY2015060I1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU92176I2 (fr) | Glycopyrronium ou un de ses sels | |
NO2021052I1 (no) | relugolix or a salt thereof | |
NL300885I2 (nl) | Irinotecansucrosofaatzout | |
LU92672I2 (fr) | Fluralaner ou un de ses sels | |
LU92137I2 (fr) | Ruxolitinib, ou un de ses sels pharmaceutiquement acceptables | |
DE502005008275D1 (de) | Backscatter transponder | |
DE602005015394D1 (de) | Schlagwerkzeug | |
DK1957719T3 (da) | Pælenedramning | |
DK1630309T3 (da) | Afløb | |
DE112005001509A5 (de) | Anprallsensor | |
DK1824382T3 (da) | Dvt-detektion | |
DE112006001054A5 (de) | Türfeststeller | |
DK1577449T3 (da) | Afløbstilslutning | |
FI20041538A0 (fi) | Goniometri | |
AT501079B1 (de) | Türe | |
ITMI20042307A1 (it) | Blocco fono-isolante | |
SE0402822D0 (sv) | A new salt | |
FIU20050330U0 (fi) | Vesivakojen avaaja | |
FR2893483B1 (fr) | Machine a depouiller ovins ou similaires | |
ITRN20040059A1 (it) | Distanziale | |
ITRN20040060A1 (it) | Distanziale | |
ES1056589Y (es) | Abrelatas mejorado | |
FR2862014B1 (fr) | Clef de vidange | |
ITMI20042278A1 (it) | Ostacolo per allenamento ginnico | |
UA11218S (uk) | Двері |